Patents by Inventor Stephane Gadelle

Stephane Gadelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10345305
    Abstract: The invention relates to a method of in-vitro detection of an infection with a hepatitis C virus (HCV) in a biological sample, comprising the simultaneous detection of the HCV capsid protein and of an antibody directed against said capsid protein, said method using, for capturing the anti-capsid antibodies, a peptide comprising an antigenic fragment derived from the truncated HCV capsid. The invention also relates to the peptide for capturing the anti-capsid antibodies and the kits comprising it.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: July 9, 2019
    Assignee: BIO-RAD INNOVATIONS
    Inventors: Stephane Gadelle, Francois Rieunier
  • Publication number: 20170328905
    Abstract: The invention relates to a method of in-vitro detection of an infection with a hepatitis C virus (HCV) in a biological sample, comprising the simultaneous detection of the HCV capsid protein and of an antibody directed against said capsid protein, said method using, for capturing the anti-capsid antibodies, a peptide comprising an antigenic fragment derived from the truncated HCV capsid. The invention also relates to the peptide for capturing the anti-capsid antibodies and the kits comprising it.
    Type: Application
    Filed: July 28, 2017
    Publication date: November 16, 2017
    Inventors: STEPHANE GADELLE, FRANCOIS RIEUNIER
  • Patent number: 9719994
    Abstract: The invention relates to a method of in-vitro detection of an infection with a hepatitis C virus (HCV) in a biological sample, comprising the simultaneous detection of the HCV capsid protein and of an antibody directed against said capsid protein, said method using, for capturing the anti-capsid antibodies, a peptide comprising an antigenic fragment derived from the truncated HCV capsid. The invention also relates to the peptide for capturing the anti-capsid antibodies and the kits comprising it.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: August 1, 2017
    Assignee: BIO-RAD INNOVATIONS
    Inventors: Stephane Gadelle, Francois Rieunier
  • Patent number: 9523685
    Abstract: The invention relates to a method for the in vitro diagnostic detection of an infection with a microorganism, comprising placing a biological sample, in a single assay receptacle, in the presence of particles, each carrying at least one specific detectable physical parameter, and belonging to at least two different groups, one of the groups carrying an anti-IgM capture antibody and the other group carrying a capture antigen derived from said microorganism.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: December 20, 2016
    Assignee: BIO-RAD INNOVATIONS
    Inventors: Christine Charpentier, Stephane Gadelle, Nadine Lambert, Amparo Sanjuan
  • Publication number: 20140335508
    Abstract: The invention relates to a method of in-vitro detection of an infection with a hepatitis C virus (HCV) in a biological sample, comprising the simultaneous detection of the HCV capsid protein, and of an antibody directed against said capsid protein, said method using, for capturing the anti-capsid antibodies, a peptide comprising an antigenic fragment derived from the truncated HCV capsid. The invention also relates to the peptide for capturing the anti-capsid antibodies and the kits comprising it.
    Type: Application
    Filed: December 19, 2012
    Publication date: November 13, 2014
    Inventors: Stephane Gadelle, Francois Rieunier
  • Publication number: 20130273525
    Abstract: The invention relates to a method for the in vitro diagnostic detection of an infection with a microorganism, comprising placing a biological sample, in a single assay receptacle, in the presence of particles, each carrying at least one specific detectable physical parameter, and belonging to at least two different groups, one of the groups carrying an anti-IgM capture antibody and the other group carrying a capture antigen derived from said microorganism.
    Type: Application
    Filed: May 13, 2013
    Publication date: October 17, 2013
    Applicant: BIO-RAD INNOVATIONS
    Inventors: CHRISTINE CHARPENTIER, STEPHANE GADELLE, NADINE LAMBERT, AMPARO SANJUAN
  • Patent number: 7988975
    Abstract: The invention involves a synthetic peptide derived from HIV-1 virus gp41 having sequence where X615 is F or G, a method of preparing the synthetic peptide, a composition and a kit containing the synthetic peptide, and use of the synthetic peptide in immunoassays for the detection of infections caused by HIV-1 viruses.
    Type: Grant
    Filed: July 27, 2005
    Date of Patent: August 2, 2011
    Assignee: Bio-Rad Pasteur
    Inventors: Stéphane Gadelle, Francois Rieunier
  • Publication number: 20100151445
    Abstract: The invention relates to a method for the in vitro diagnostic detection of an infection with a microorganism, comprising placing a biological sample, in a single assay receptacle, in the presence of particles, each carrying at least one specific detectable physical parameter, and belonging to at least two different groups, one of the groups carrying an anti-IgM capture antibody and the other group carrying a capture antigen derived from said microorganism.
    Type: Application
    Filed: June 6, 2008
    Publication date: June 17, 2010
    Applicant: BIO-RAD PASTEUR
    Inventors: Christine Charpentier, Stephane Gadelle, Nadine Lambert, Amparo Sanjuan
  • Publication number: 20090263785
    Abstract: The invention relates to synthetic peptides having sequence (III), which are derived from HIV-1 virus gp41 and which can be used in immunoassays for the detection of infections caused by HIV-1 viruses. The invention also relates to the method of preparing said peptides, to compositions and kits containing same and to the use thereof for diagnostic purposes. The invention further relates to immunoassays which use said peptides for the detection of anti-HIV virus antibodies.
    Type: Application
    Filed: July 27, 2005
    Publication date: October 22, 2009
    Applicant: BIO-RAD PASTEUR
    Inventors: Stephane Gadelle, Francois Rieunier
  • Patent number: 6027874
    Abstract: Immunoenzymatic conjugate consisting of glycosylated labelling enzymes in copolymer form and substances having immunological activity.Method for the production of the conjugates according to the invention and use of the said conjugates in diagnostic kits.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: February 22, 2000
    Assignee: Pasteur Sanofi Diagnostics
    Inventors: Christophe Cucurou, Gilles Cognet, Stephane Gadelle, Carine Le Sager